Skip to main content

Table 1 Immunohistochemistry score of P-cadherin in each histological subtype

From: Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study

A: Intensity score (IS)
Histologic type   Intensity score (%)
n 0 1 2 3
Clear cell 34 18 (52.9) 13 (38.2) 3 (8.8) 0 (0)
Endometrioid 30 1 (3.3) 8 (26.7) 16 (53.3) 5 (16.7)
Mucinous 23 5 (21.7) 7 (30.4) 10 (43.5) 1 (4.4)
Serous 75 7 (9.3) 14 (18.7) 44 (58.7) 10 (13.3)
All patients 162 31 (19.1) 42 (25.9) 73 (45.1) 16 (9.9)
B: Positive percent score (PPS)
Histologic type   Positive percentage score (%)
n 0 1 2 3
Clear cell 34 18 (52.9) 6 (17.6) 6 (17.6) 4 (11.8)
Endometrioid 30 1 (3.3) 7 (23.3) 2 (6.7) 20 (66.7)
Mucinous 23 5 (21.7) 3 (13.0) 4 (17.4) 11 (47.8)
Serous 75 7 (9.3) 6 (8.0) 9 (12.0) 53 (70.7)
All patients 162 31 (19.1) 22 (13.5) 21 (13.0) 88 (54.3)
C: P-cadherin score (Sum of IS and PPS)
Histologic type    Total score (%)
  n Low High
Clear cell   34 30 (88.2) 4 (11.8)
Endometrioid   30 9 (30.0) 21 (70.0)
Mucinous   23 12 (52.2) 11 (47.8)
Serous   75 16 (21.3) 59 (78.7)
All patients   162 67 (41.4) 95 (58.6)
  1. Immunohistochemistry score of P-cadherin in each histological subtype. a: intensity score, b: positive percentage score, c: P-cadherin score